186 related articles for article (PubMed ID: 10414722)
1. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
Rabbani F; Russo P
Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
[TBL] [Abstract][Full Text] [Related]
2. Association between non-Hodgkin lymphoma and renal cell carcinoma.
Lossos C; Ferrell A; Duncan R; Lossos IS
Leuk Lymphoma; 2011 Dec; 52(12):2254-61. PubMed ID: 21740306
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
Rabbani F; Reuter VE; Katz J; Russo P
Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
7. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of non-Hodgkin's lymphoma complicated by renal cell malignancies.
Ohsawa M; Hashimoto M; Yasunaga Y; Shingu N; Aozasa K
Oncology; 1998; 55(5):482-6. PubMed ID: 9732229
[TBL] [Abstract][Full Text] [Related]
9. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
Hemminki K; Lenner P; Sundquist J; Bermejo JL
J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
[TBL] [Abstract][Full Text] [Related]
10. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
11. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
Broccia G; Cocco P; Casula P;
Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
[TBL] [Abstract][Full Text] [Related]
12. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.
Murray KS; Zabor EC; Spaliviero M; Russo P; Bazzi WM; Musser JE; Ari Hakimi A; Bernstein ML; Dalbagni G; Coleman JA; Furberg H
World J Urol; 2016 Dec; 34(12):1667-1672. PubMed ID: 27106493
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients diagnosed with both melanoma and renal cell cancer.
Abern MR; Tsivian M; Coogan CL; Kaufman HL; Polascik TJ
Cancer Causes Control; 2013 Nov; 24(11):1925-33. PubMed ID: 23897487
[TBL] [Abstract][Full Text] [Related]
15. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary malignancies in renal cell carcinoma.
Rabbani F; Grimaldi G; Russo P
J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
[TBL] [Abstract][Full Text] [Related]
17. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
20. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]